
Resourceful Clinical Research Coordinator with strong organizational skills and detail-oriented team player. Ability to handle multiple projects simultaneously with a high degree of accuracy.
Good Clinical Practice Certification
IATA Certification
High School Diploma
Canfield Photography
Medidata Rave
RealTime CTMS
eCaselink
C-SSRS
Signant Health
TrialManager
eCOA
InvestigatorSpace
Lifesphere
CardioCore
LabCorp
VANDA
LabConnect
Medpace
Study Coordinating History
- A multicenter, randomized, double-blind, placebo-controlled phase III study to assess the efficacy of XXXXX relieving symptoms of gastroparesis.
- Motion Syros: A randomized, double-blind, placebo-controlled study to investigate the efficacy of XXXXX in subjects affected by motion sickness during travel.
- A randomized, double-blind, placebo-controlled phase II study to evaluate efficacy, pharmacokinetics, and safety of multiple intravenous doses of XXXXX in adults with Atopic Dermatitis.
- A phase 2b, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of XXXXX in adult patients with non-responsive celiac disease as an adjunct to a gluten-free diet.
- A phase 2 randomized, double-blind, placebo-controlled, parallel-group study of the safety and efficacy of XXXXX administered orally to patients with gastroparesis.
- A phase 2b, randomized, placebo-controlled, multicenter study to evaluate the safety and efficacy of XXXXX versus Placebo in Gout Patients.
- Motion Delos: An open-label study to investigate the safety and efficacy of XXXXX in participants affected by motion sickness during travel.
- A randomized, double-blind, placebo-controlled, efficacy study of the XXXXX receptor antagonist XXXXX in patients with Atopic Dermatitis.
- A 12-week, single-blind, placebo-controlled randomized study to evaluate the safety, tolerability, and physiological regulation of an amino acid food product, XXXXX, in subjects with mild to moderate hepatic insufficiency.
- A phase II, randomized, double-blind, placebo-controlled study of XXXXX in patients with moderate to severe Hidradenitis Suppurativa.
- A phase II, randomized, double-blind, placebo-controlled study of XXXXX in patients with moderate to severe Atopic Dermatitis.